Wang Minjia

Wang Minjia has work experience as an Analytical Scientist at Prime Medicine, Inc. from January 2023 onwards. Prior to that, they worked as a Research Assistant at the University of Mississippi from August 2017 to December 2022. In this role, they were involved in nano formulation development, pharmacokinetic studies of organic CO prodrugs, evaluating innate immunity enhancement effects, and intracellular delivery of STING agonist for cancer immunotherapy.

Wang Minjia earned a Bachelor of Engineering (BE) degree in Biochemical Engineering from the University of Iowa, where they studied between 2012 and 2016. Wang then pursued a Doctor of Philosophy (PhD) degree in Pharmaceutical Sciences at the University of Mississippi from 2017 to 2022. In addition, Wang Minjia obtained a Certificate for hands-on tablet technology from the University of Mississippi in 2018.